Results of a Randomized Augmented Intensification Phase in Acute Lymphoblastic Leukemia in Children in Argentina: GATLA 2010 ALL IC Trial

Documenti analoghi

• Risk‐Stratified and Response‐Adapted Therapy for Pediatric Hodgkin Lymphoma in Argentina: The GATLA Experience
  di: David Veron, et al.
  Pubblicazione: (2025)
• Bridging the Gap in Pediatric Relapsed Acute Lymphoblastic Leukemia Treatment: Insights and Outcomes From the ALL‐IC REL 2016 Guidelines
  di: Marko Kavcic, et al.
  Pubblicazione: (2025)
• A study on deep feature extraction to detect and classify Acute Lymphoblastic Leukemia (ALL)
  di: Preanto, Sabit Ahamed, et al.
  Pubblicazione: (2024)
• Adherence to 6‐Mercaptopurine (6‐MP) and Habit Strength in Pediatric Acute Lymphoblastic Leukemia (ALL)
  di: Mira Muxi Yang, et al.
  Pubblicazione: (2025)
• Diagnostically Challenging but Infrequent Aberrant Immunophenotypic Patterns in B‐Lymphoblastic Leukemia/Lymphoma (B‐ALL)
  di: Kritika Krishnamurthy, et al.
  Pubblicazione: (2025)